SARAH KRESSY: Open Payments
NPI 1578865267 · LOUISVILLE, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$281 in 12 payments from 11 companies in 2025. Trend: 2023 $384 · 2024 $352 · 2025 $281
Food & beverage: $281
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $47 |
| Sumitomo Pharma America, Inc. | 1 | $28 |
| Abbott Laboratories | 1 | $25 |
| Amneal Pharmaceuticals LLC | 1 | $24 |
| PFIZER INC. | 1 | $23 |
| Novo Nordisk Inc | 1 | $23 |
| ABBVIE INC. | 1 | $23 |
| Lilly USA, LLC | 1 | $23 |
| Cleerly, Inc. | 1 | $22 |
| Exact Sciences Corporation | 1 | $22 |
Products named: OTEZLA, GEMTESA, FREESTYLE LIBRE 3, UNITHROID, ELIQUIS, Ozempic, UBRELVY, MOUNJARO.
Industry payments across CO — which companies pay providers there.
